A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)
George Pentheroudakis(University of Ioannina), George Fountzilas(Aristotle University of Thessaloniki), Elpida Charalambous(Aristotle University of Thessaloniki), Pavlos Papakostas(Hippocration General Hospital), Epaminontas Samantas(Metropolitan Hospital), Demetris Papamichael(Bank of Cyprus Oncology Center), Vassiliki Kotoula(Aristotle University of Thessaloniki), Nicholas Pavlidis(University of Ioannina), Ioannis Varthalitis(Chania General Hospital ”St. George”), Elena Fountzilas(European University Cyprus), Evangelia Razis(Hygeia Hospital), Ioannis Xanthakis(Aristotle University of Thessaloniki), Christos Christodoulou(Metropolitan Hospital), Dimitrios Bafaloukos(Metropolitan Hospital), George Kouvatseas, George Basdanis(Aristotle University of Thessaloniki), Thomas Makatsoris(University of Patras)
Cited by 35
Related Papers
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2014|760
Review of precision cancer medicine: Evolution of the treatment paradigm
|Cancer Treatment Reviews|2020|747
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
|Annals of Oncology|2017|591
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
|Journal of Clinical Oncology|2010|488
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|393